US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Halobetasol Propionate Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 63739-998-67 D-0691-2022
Class II · Moderate risk Terminated

Hydrocortisone Butyrate Lotion 0.1%

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 51862-159-04 D-0690-2022
Class II · Moderate risk Terminated

Halobetasol Propionate Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-073-15 D-0689-2022
Class II · Moderate risk Terminated

Halobetasol Propionate Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-033-50 D-0688-2022
Class II · Moderate risk Terminated

Gentamicin Sulfate Ointment USP 0.1%

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-090-15 D-0687-2022
Class II · Moderate risk Terminated

Gentamicin Sulfate Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-085-15 D-0686-2022
Class II · Moderate risk Terminated

Fluocinonide Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk Terminated

Fluocinonide Gel USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022
Class II · Moderate risk Terminated

Fluocinonide Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-079-11 D-0683-2022
Class II · Moderate risk Terminated

Econazole Nitrate Cream

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-022-15 D-0682-2022
Class II · Moderate risk Terminated

Diflorasone Diacetate Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-031-60 D-0681-2022
Class II · Moderate risk Terminated

Diclofenac Sodium Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-025-05 D-0680-2022
Class II · Moderate risk Terminated

Diclofenac Sodium Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-002-05 D-0679-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-030-99 D-0678-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-045-99 D-0677-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-037-10 D-0676-2022
Class II · Moderate risk Terminated

Desonide Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-038-15 D-0675-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Gel

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-082-15 D-0674-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-039-15 D-0673-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Lotion

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-055-02 D-0672-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-094-15 D-0671-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-051-15 D-0670-2022
Class II · Moderate risk Terminated

Betamethasone Dipropionate Lotion USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-023-29 D-0669-2022
Class II · Moderate risk Terminated

PHENOBARBITAL Sodium Injection

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Vitae Enim Vitae Scientific, Inc. NDC 42494-416-25 D-0744-2022
Class II · Moderate risk Terminated

PHENOBARBITAL Sodium Injection

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Vitae Enim Vitae Scientific, Inc. NDC 42494-415-25 D-0743-2022